Wikidata

(Q62025051)

English

Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

title
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
country
Canada
0 references
main subject
dermatitis
0 references
start time
29 September 2018
0 references
end time
August 2021
0 references
number of participants
256
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62025051&oldid=2076358555"